Ligand validation:4X93

NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose

NAG is a Ligand Of Interest in 4X93 designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
4X93_NAG_B_404	40%	64%	0.213	0.925	0.5	0.86	-	-	0	0	100%	0.9333
4X93_NAG_A_404	36%	62%	0.236	0.932	0.51	0.93	-	1	0	0	100%	0.9333
4X93_NAG_A_402	36%	52%	0.209	0.902	0.6	1.24	-	1	0	0	100%	0.9333
4X93_NAG_A_401	35%	58%	0.263	0.954	0.64	0.97	-	1	0	0	100%	0.9333
4X93_NAG_B_401	22%	62%	0.32	0.941	0.55	0.88	-	-	0	0	100%	0.9333
4X93_NAG_B_402	21%	55%	0.239	0.85	0.61	1.13	-	1	0	0	100%	0.9333
4X93_NAG_A_403	6%	43%	0.297	0.729	0.71	1.46	-	4	0	0	100%	0.9333
4X93_NAG_B_403	4%	37%	0.292	0.679	0.61	1.83	-	4	0	0	100%	0.9333
4X90_NAG_A_404	85%	57%	0.077	0.94	0.58	1.08	-	1	0	0	100%	0.9333
4X91_NAG_B_404	82%	57%	0.105	0.961	0.42	1.2	-	2	0	0	100%	0.9333
4X97_NAG_D_403	79%	24%	0.107	0.954	0.95	2.14	1	8	1	0	100%	0.9333
4X92_NAG_A_401	67%	57%	0.163	0.973	0.53	1.12	-	2	0	0	100%	0.9333
4X94_NAG_A_404	63%	50%	0.182	0.978	0.6	1.31	-	1	0	0	100%	0.9333
3H0C_NAG_A_794	100%	56%	0.021	0.995	0.61	1.08	-	1	0	0	100%	0.9333
5LDS_NAG_B_1007	100%	67%	0.022	0.995	0.48	0.79	-	-	0	0	100%	0.9333
5O5D_NAG_A_601	100%	65%	0.022	0.994	0.32	0.99	-	1	0	0	100%	0.9333
6MUG_NAG_G_629	100%	76%	0.022	0.994	0.35	0.58	-	-	0	0	100%	0.9333
3PPS_NAG_B_760	100%	44%	0.028	0.993	0.57	1.57	-	3	0	0	100%	0.9333

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.